keyword
https://read.qxmd.com/read/38642125/surgical-management-of-rectal-cancer-with-synchronous-treatment-of-prostate-cancer
#21
JOURNAL ARTICLE
Raphaëlle Brière, André-Guy Martin, François Letarte, François Rouleau Fournier, Philippe Bouchard, Sébastien Drolet
PURPOSE: To assess the safety and efficacy of synchronous treatments for rectal (RC) and prostate (PC) cancers. METHODS: Single-center retrospective study (2007-2021) of patients treated with neoadjuvant radiotherapy (RT) and total mesorectal excision (TME) for RC with synchronous PC treatment. The endpoints were 30-day postoperative severe complications, R0 resection rates, 3-year disease-free survival (DFS) and 3-year overall survival (OS). RESULTS: Among the 16 patients, 15 (93...
April 20, 2024: Langenbeck's Archives of Surgery
https://read.qxmd.com/read/38642093/prognostic-performance-of-mri-li-rads-version-2018-features-and-clinical-pathological-factors-in-alpha-fetoprotein-negative-hepatocellular-carcinoma
#22
JOURNAL ARTICLE
Leyao Wang, Bing Feng, Meng Liang, Dengfeng Li, Rong Cong, Zhaowei Chen, Sicong Wang, Xiaohong Ma, Xinming Zhao
PURPOSE: To evaluate the role of the magnetic resonance imaging (MRI) Liver Imaging Reporting and Data System (LI-RADS) version 2018 features and clinical-pathological factors for predicting the prognosis of alpha-fetoprotein (AFP)-negative (≤ 20 ng/ml) hepatocellular carcinoma (HCC) patients, and to compare with other traditional staging systems. METHODS: We retrospectively enrolled 169 patients with AFP-negative HCC who received preoperative MRI and hepatectomy between January 2015 and August 2020 (derivation dataset:validation dataset = 118:51)...
April 20, 2024: Abdominal Radiology
https://read.qxmd.com/read/38641474/natural-history-and-health-care-burden-of-non-curative-treatment-for-muscle-invasive-bladder-cancer
#23
JOURNAL ARTICLE
Haim Herzberg, Yossi Ventura, Karin Lifshitz, Ziv Savin, Shay Golan, Jack Baniel, Ofer Yossepowitch, Roy Mano
OBJECTIVE: Muscle-invasive bladder cancer is an aggressive disease. Yet, many patients, especially those with advanced age and multiple comorbidities, do not receive treatment with curative intent. We evaluated the disease course and health care burden of these patients. MATERIALS AND METHODS: Bi-center, retrospective analysis of patients diagnosed with muscle-invasive bladder cancer who did not undergo curative-intent treatment (radical cystectomy or trimodal therapy) between 2016 and 2021...
April 18, 2024: Urologic Oncology
https://read.qxmd.com/read/38641443/site-specific-differences-of-eligibility-for-adjuvant-immunotherapy-among-urothelial-carcinoma-patients-treated-with-radical-surgery-results-from-a-multicenter-cohort-study
#24
JOURNAL ARTICLE
Chisato Narita, Fumihiko Urabe, Wataru Fukuokaya, Kosuke Iwatani, Yu Imai, Keiji Yasue, Keiichiro Mori, Koichi Aikawa, Takafumi Yanagisawa, Shoji Kimura, Kojiro Tashiro, Shunsuke Tsuzuki, Yuta Yamada, Steffi Kar Kei Yuen, Jeremy Yuen-Chun Teoh, Tatsuya Shimomura, Hiroki Yamada, Akira Furuta, Jun Miki, Takahiro Kimura
BACKGROUND: The CheckMate274 trial has reported enhanced disease-free survival rates in patients with stage pT3-4/ypT2-4 or pN+ urothelial carcinoma (UC) undergoing adjuvant nivolumab therapy. This study compares prognostic differences between urothelial carcinoma of the bladder (UCB) and upper tract urothelial carcinoma (UTUC). METHODS: We retrospectively analyzed data from 719 patients with UC who underwent radical surgery, stratifying to patients at stage pT3-4 and/or pN+ without neoadjuvant chemotherapy (NAC) or at ypT2-4 and/or ypN+ with NAC (potential candidates for adjuvant immunotherapy), and to those who were not candidates for adjuvant immunotherapy...
March 21, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38641249/the-prognostic-nutritional-index-as-a-predictor-of-efficacy-and-early-recurrence-for-adjuvant-transarterial-chemoembolization-in-hepatocellular-carcinoma
#25
JOURNAL ARTICLE
Xinting Pan, En Hu, Yang Zhou, Ling Li, Xinhui Huang, Zhixiong Cai
BACKGROUND AND AIMS: Postoperative adjuvant transcatheter arterial chemoembolization (TACE) can prevent recurrence of hepatocellular carcinoma (HCC) in certain patients. This study aimed to identify the potential beneficiaries of adjuvant TACE. METHODS: 477 patients who underwent curative resection for HCC were enrolled in this retrospectively cohort study. The trajectory of the prognostic nutritional index (PNI) during the perioperative period was fitted using a latent-class growth mixed model...
April 17, 2024: Clinics and Research in Hepatology and Gastroenterology
https://read.qxmd.com/read/38641234/salvage-stereotactic-radiosurgery-for-recurrent-who-grade-2-and-3-meningiomas-a-multicenter-study-storm
#26
JOURNAL ARTICLE
Matthew Gallitto, Geoffrey Sedor, Albert Lee, Jared Pasetsky, Connor J Kinslow, Genesis De Los Santos, Derrick Obiri-Yeboah, Varun R Kshettry, Corbin A Helis, Michael D Chan, Thomas H Beckham, Susan L McGovern, Jennifer Matsui, Joshua D Palmer, Jonathan B Bell, Eric A Mellon, David Lakomy, Jiayi Huang, Ian Boor, Chad G Rusthoven, Michael B Sisti, Tony J C Wang
PURPOSE: The role of stereotactic radiosurgery (SRS) in the management of grade 2 and 3 meningiomas is not well elucidated. Unfortunately, local recurrence rates are high, and guidelines for management of recurrent disease are lacking. To address this knowledge gap, we conducted STORM, a multicenter retrospective cohort study of patients treated with primary SRS for recurrent grade 2 and 3 meningiomas. METHODS AND MATERIALS: Data on patients with recurrent grade 2 and 3 meningioma treated with SRS at first recurrence were retrospectively collected from eight academic centers in the United States...
April 17, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38640773/secondary-cytoreductive-surgery-and-oncologic-outcomes-in-the-era-of-targeted-maintenance-therapy-for-recurrent-platinum-sensitive-ovarian-cancer
#27
JOURNAL ARTICLE
Sarah Ehmann, Clarissa Lam, Qin Zhou, Alexia Iasonos, Rachel N Grisham, William P Tew, Roisin E O'Cearbhaill, Kara Long Roche, Oliver Zivanovic, Yukio Sonoda, Dennis S Chi, Ginger J Gardner
OBJECTIVES: To compare oncologic outcomes of secondary cytoreductive surgery (SCS) before and after FDA approval of Poly(ADP-ribose) polymerase inhibitor (PARPi) and bevacizumab maintenance therapies for platinum-sensitive recurrent ovarian cancer (PS-ROC). METHODS: Patients who underwent SCS for first recurrence of PS-ROC from 1/1/2013-1/1/2020 were identified. Exclusion criteria included prior chemotherapy for recurrence, bowel obstruction procedures, and palliative surgery...
April 18, 2024: Gynecologic Oncology
https://read.qxmd.com/read/38640334/prognostic-significance-of-systemic-inflammatory-parameters-in-high-grade-glial-tumor-patients-two-center-experience
#28
JOURNAL ARTICLE
Sukran Oztep Eskici, Eda Bengi Yilmaz
We aimed to determine the prognostic values of the neutrophil-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, body mass index, and prognostic nutritional index scores in patients with high-grade glioma. This was a retrospective observational case series. Between 2015 and 2020, 79 patients with high-grade gliomas 2 oncology centers were included in our study. All patients (n = 79) had high-grade glial tumors and were treated with RT. Sixty-nine (87.3%) patients died, and the median 2 years overall survival was 12...
April 19, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38639661/-study-on-the-efficacy-and-complications-of-patients-undergoing-radical-surgery-and-radical-radiotherapy-for-localized-prostate-cancer
#29
JOURNAL ARTICLE
Xiu-Quan Shi, Shi-Hao Wang, Zhe Liu, Long-Wei Lu, Song Xu, Dian Fu, Wen Cheng
OBJECTIVE: To compare the efficacy and complications of radical surgery (RP) and radical radiotherapy (RRT). METHODS: The clinical data of patients diagnosed with localized prostate cancer in General Hospital of Eastern Theater Command with RP and RRT from January 2015 to December 2019, Observed and recorded patient preoperative and postoperative PSA levels, biochemical Relapse-free Survival and clinical Relapse-free Survival,and the occurrence of hematuria, urinary incontinence, erectile dysfunction, ankylurethria, diarrhea, hemoproctia and radiocystitis...
October 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38638849/oncolytic-virotherapy-stimulates-anti%C3%A2-tumor-immune-response-and-demonstrates-activity-in-advanced-sarcoma-report-of-two-cases
#30
Yeting Qiu, Aijun Qin, Ronghua Zhao, Jun Ding, William Wei-Guo Jia, Manu Singh, Yanal Murad, Qian Tan, Ganessan Kichenadasse
Sarcoma is derived from mesenchymal neoplasms and has numerous subtypes, accounting for 1% of all adult malignancies and 15% of childhood malignancies. The prognosis of metastatic or recurrent sarcoma remains poor. The current study presents two cases of sarcoma enrolled in a phase I dose escalation trial for solid tumor, who had previously failed all standard therapies. These patients were treated with VG161, an immune-stimulating herpes simplex virus type 1 oncolytic virus with payloads of IL-12, IL-15 and IL-15 receptor α unit, and a programmed cell death 1 (PD-1)/PD-1 ligand 1 blocking peptide...
June 2024: Oncology Letters
https://read.qxmd.com/read/38637966/analysis-of-response-and-progression-patterns-of-tyrosine-kinase-inhibitors-in-recurrent-or-metastatic-adenoid-cystic-carcinoma-a-post-hoc-analysis-of-two-kcsg-phase-ii-trials
#31
JOURNAL ARTICLE
Youjin Kim, Bhumsuk Keam, Eun Joo Kang, Jin-Soo Kim, Hye Ryun Kim, Keun-Wook Lee, Jung Hye Kwon, Kyoung Eun Lee, Yaewon Yang, Yoon Hee Choi, Min Kyoung Kim, Jun Ho Ji, Tak Yun, Moon Young Choi, Ki Hyeong Lee, Sung-Bae Kim, Myung-Ju Ahn
PURPOSE: In this study, we evaluated 66 patients diagnosed with adenoid cystic carcinoma (ACC) enrolled in two Korean Cancer Study Group trials to investigate the response and progression patterns in recurrent and/or metastatic ACC treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs). MATERIALS AND METHODS: We evaluated 66 patients diagnosed with ACC who were enrolled in the Korean Cancer Study Group trials. The tumor measurements, clinical data, treatment outcomes, and progression patterns of therapy were analyzed...
April 15, 2024: Cancer Research and Treatment: Official Journal of Korean Cancer Association
https://read.qxmd.com/read/38637800/primary-lymphoma-of-the-female-genital-tract-masquerading-as-gynecological-malignancy
#32
JOURNAL ARTICLE
Suhua Shi, Wuan Li, Guantai Ni, Jin Ding, Yinhua Liu, Haixing Wu, Zhen Zhang, Zhimin Ding
BACKGROUND: Primary lymphoma of the female genital tract (PLFGT) is a rare malignant tumor in the female reproductive system, with a low incidence and few clinical reports. The aim of this study is to report our institutional experience with this rare malignancy and emphasize the need for increasing the awareness about PLFGT presenting with gynecologic symptoms. METHODS: The medical records of patients diagnosed with PLFGT from March 2014 to November 2022 in the First Affiliated Hospital of Wannan Medical College were reviewed...
April 18, 2024: BMC Women's Health
https://read.qxmd.com/read/38637772/anti-pd-1-antibody-in-combination-with-radiotherapy-as-first-line-therapy-for-unresectable-intrahepatic-cholangiocarcinoma
#33
JOURNAL ARTICLE
Meiyan Zhu, Meng Jin, Xiao Zhao, Shunli Shen, Yihan Chen, Han Xiao, Guangyan Wei, Qiang He, Bin Li, Zhenwei Peng
BACKGROUND: Unresectable intrahepatic cholangiocarcinoma (iCCA) has a poor prognosis despite treatment with standard combination chemotherapy. We aimed to evaluate the efficacy and safety of radiotherapy in combination with an anti-PD-1 antibody in unresectable iCCA without distant metastases. METHODS: In this phase II study, patients with histopathologically confirmed unresectable primary or postoperative recurrent iCCA without distant metastases were enrolled...
April 19, 2024: BMC Medicine
https://read.qxmd.com/read/38637344/effects-of-transmembrane-serine-protease-4-on-the-survival-in-patients-with-pancreatic-ductal-adenocarcinoma-undergoing-surgery-followed-by-adjuvant-chemotherapy
#34
JOURNAL ARTICLE
Sho Tazuma, Takeshi Sudo, Akira Ishikawa, Atsushi Yamaguchi, Yoshiyuki Shibata, Yuko Ishida, Kazuya Kuraoka, Kenichiro Uemura, Shinya Takahashi, Hirotaka Tashiro
PURPOSE: The transmembrane serine protease 4 (TMPRSS4) gene is upregulated in various human cancers. However, its biological functions in pancreatic ductal adenocarcinoma remain unclear. We examined the expression of TMPRSS4 in pancreatic ductal adenocarcinoma tissues and its correlation with clinicopathological parameters in patients with pancreatic ductal adenocarcinoma who underwent surgery. METHODS: The TMPRSS4 expression was immunohistochemically examined in 81 PDAC patients with pancreatic ductal adenocarcinoma...
April 19, 2024: Surgery Today
https://read.qxmd.com/read/38636930/regional-conduction-velocities-determined-by-non-invasive-mapping-are-associated-with-arrhythmia-free-survival-after-atrial-fibrillation-ablation
#35
JOURNAL ARTICLE
Eric Invers-Rubio, Ismael Hernández-Romero, Jana Reventos-Presmanes, Elisenda Ferro, Jean-Baptiste Guichard, Mariona Regany-Closa, Berta Pellicer-Sendra, Roger Borras, Susanna Prat-Gonzalez, Jose Maria Tolosana, Andreu Porta-Sanchez, Elena Arbelo, Eduard Guasch, Marta Sitges, Josep Brugada, Maria S Guillem, Ivo Roca-Luque, Andreu M Climent, Lluís Mont, Till F Althoff
BACKGROUND: Atrial arrhythmogenic substrate is a key determinant of atrial fibrillation (AF) recurrence after pulmonary vein isolation (PVI), and reduced conduction-velocities have been linked to adverse outcome. However, a non-invasive method to assess such electrophysiological substrate is not available to date. OBJECTIVE: This study aimed to non-invasively assess regional conduction-velocities and their association with arrhythmia-free survival following PVI...
April 16, 2024: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://read.qxmd.com/read/38636710/re-irradiation-versus-systemic-therapy-for-the-management-of-local-regionally-recurrent-head-and-neck-cancer
#36
JOURNAL ARTICLE
Allen M Chen, Jeremy P Harris, Rupali Nabar, Tjoson Tjoa, Yarah Haidar, William B Armstrong
PURPOSE: The optimal management of local-regionally recurrent head and neck cancer that is not amenable to surgical resection is uncertain. We sought to compare outcomes among patients treated with and without re-irradiation in this setting. METHODS AND MATERIALS: A review of institutional registries identified 65 patients with local-regionally recurrent squamous cell carcinoma of the head and neck who were ineligible for surgery. Forty patients (62 %) opted for re-irradiation with the remaining 25 patients (38 %) undergoing initial systemic therapy alone...
April 16, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38636548/surgical-resection-and-reconstruction-of-ameloblastoma-a-13-year-retrospective-review
#37
JOURNAL ARTICLE
Cheryl Chen, Martin Batstone, Touraj Taheri, Nigel Johnson
BACKGROUND: Ameloblastoma is a locally aggressive, benign tumor presenting in the maxilla and mandible prone to recurrence. Resection greatly limits recurrence; however, reconstruction becomes critical to preserve patients' functionality and esthetics. PURPOSE: The aim of this study was to describe surgical resection and reconstructive approaches in the treatment of ameloblastoma and compare clinical outcomes to conservative methods of treatment. STUDY DESIGN, SETTING, SAMPLE: A retrospective case series was completed through analysis of patient records...
April 1, 2024: Journal of Oral and Maxillofacial Surgery
https://read.qxmd.com/read/38636183/role-of-diagnostic-laparoscopy-during-pancreatic-cancer-surgery-in-the-modern-era
#38
JOURNAL ARTICLE
Jeremy Chang, Scott K Sherman, James P De Andrade, Hisakazu Hoshi, James R Howe, Carlos H F Chan
INTRODUCTION: Despite improvements in preoperative image resolution, approximately 10% of curative-intent resection attempts for pancreatic ductal adenocarcinoma are aborted at the time of operation. To avoid nontherapeutic laparotomy, many surgeons perform intraoperative diagnostic laparoscopy (DL) to identify radiographically occult metastatic disease. There are no consensus guidelines regarding DL in pancreatic cancer. The goal of this study is to investigate the efficacy of same-procedure DL at avoiding nontherapeutic laparotomy...
April 17, 2024: Journal of Surgical Research
https://read.qxmd.com/read/38635903/cd58-alterations-govern-antitumor-immune-responses-by-inducing-pd-l1-and-ido-in-diffuse-large-b-cell-lymphoma
#39
JOURNAL ARTICLE
Xiyue Xu, Yidan Zhang, Yaxiao Lu, Xiaoyan Zhang, Cuicui Zhao, Jiesong Wang, Qingpei Guan, Yingfang Feng, Meng Gao, Jingwei Yu, Zheng Song, Xia Liu, Zahra Golchehre, Lanfang Li, Weicheng Ren, Qiang Pan-Hammarström, Huilai Zhang, Xianhuo Wang
Recurrent abnormalities in immune surveillance-related genes affect the progression of diffuse large B-cell lymphoma (DLBCL) and modulate the response to therapeutic interventions. CD58 interacts with the CD2 receptor on T cells and natural killer (NK) cells and is recurrently mutated and deleted in DLBCL, suggesting it may play a role in regulating antitumor immunity. Herein, we comprehensively analyzed the genomic characteristics of CD58 through targeted next-generation sequencing, RNA-sequencing, whole-exome sequencing, and single-cell RNA-sequencing in patients with newly diagnosed DLBCL...
April 18, 2024: Cancer Research
https://read.qxmd.com/read/38635652/protocol-for-a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-nivolumab-as-a-postoperative-adjuvant-therapy-for-patients-with-esophageal-cancer-treated-with-preoperative-docetaxel-cisplatin-plus-5-fluorouracil-treatment-pentagon-trial
#40
JOURNAL ARTICLE
Hironobu Goto, Taro Oshikiri, Takashi Kato, Yoshiaki Nagatani, Yohei Funakoshi, Yasufumi Koterazawa, Ryuichiro Sawada, Hitoshi Harada, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Kimihiro Yamashita, Takeru Matsuda, Hironobu Minami, Yoshihiro Kakeji
BACKGROUND: In Japan, preoperative adjuvant chemotherapy followed by surgical resection is the standard treatment for patients with locally advanced esophageal squamous cell carcinoma. However, the risk of recurrence after surgical resection remains high. Although a randomized controlled trial evaluating the efficacy of nivolumab, a fully human monoclonal anti-programmed death 1 antibody, as postoperative adjuvant therapy after neoadjuvant chemoradiotherapy and surgery established its superior efficacy as adjuvant therapy, the efficacy for patients who received preoperative adjuvant chemotherapy has not been demonstrated...
2024: PloS One
keyword
keyword
119234
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.